The Future is Bright for Stem Cell Treatments
Considering the many emerging research studies on possible cord blood and cord tissue stem cell use, the future of stem cell treatments is very bright. Only the surface has been scratched when it comes to discovering the potential of these cells to treat diseases and disorders. New technologies that allow for the expansion of cord blood cells means that effective autologous therapy will be achievable well into adulthood. Additionally, research has shown that cord blood stem cells can also be effectively used for regeneration or repair, of non-hematopoietic tissues, such as the repair of joint damage through cartilage regeneration. Studies have also demonstrated that these cells are effective at modulating/reducing inflammation, and in the treatment of neurological disorders (ie. ALS, Alzheimer’s Disease, Stroke) that can occur later in life. Keeping up with the latest news inspires hope in the future.
Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells and isolation of endothelial progenitors from 21- to 23.5 year cryopreserved cord blood
Cryopreservation of hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) is crucial for cord blood (CB) banking and transplantation. We evaluated recovery of functional HPC cryopreserved as mononuclear or unseparated cells for up to 23.5 years compared with prefreeze values of the same CB units.
A low frequency of pancreatic islet insulin-expressing cells derived from cord blood stem cell allografts in humans
Umbilical cord blood cells do have the capacity to migrate to the pancreatic islet and differentiate into insulin-expressing cells in humans. This is in contrast to the absence of insulin-expressing cells with an opposite-sex complement of sex chromosomes present in human pancreas after prior bone marrow transplant, when the same methods were used as here.
Enhanced cord blood stem cell transplants safe in long-term studies
An innovative experimental treatment for boosting the effectiveness of stem-cell transplants with umbilical cord blood has a favorable safety profile in long-term animal studies, report scientists from Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center and Children's Hospital Boston.
Cord blood stem cells used to help cure girl of brain cancer in Spain
A four-year-old girl, diagnosed with a rare form of brain cancer, became the first patient in Spain to recover from brain cancer after being treated with stem cells from her own umbilical cord blood. The use of stem cells to regenerate the blood system is an extended treatment for this form of cancer.
Cord Blood Breakthroughs
It's already helping cancer patients and those suffering from blood disorders. Now, doctors are using umbilical cord blood to tackle a new set of conditions. From brain damage to diabetes, cord blood is giving kids a better life. A stroke at birth caused 6-year-old Max's cerebral palsy. He's one of 150 kids getting infusions of his own cord blood at Duke University.
Fred Hutchison breakthrough uses umbilical cord blood
A major breakthrough in cancer treatment has been by scientists here in Washington. The Fred Hutchinson Cancer Center cleared a hurdle in the use of umbilical cord blood - using a new life to help save another. The breakthrough could make umbilical-cord-blood transplants a more widely-used method for treating blood cancers like leukemia.
New Hope in Alzheimer's Through Stem Cells
In recent years, the science community has been working hard to discover the many uses of stem cells. While some consider the study of stem cells to be controversial, the findings have continued to show endless possibilities. In recent studies, researchers have found a link between stem cells and restoring memory capabilities.
Adding stem cells to common bypass surgery may reduce heart failure
In a new research study under way at the Methodist DeBakey Heart & Vascular Center, surgeons are adding a patient’s own stem cells to the heart during cardiac bypass surgery. The goal of this research study is to determine whether the stem cell infusion will generate new blood vessels and improve heart function.
Duke gets $10.2M grant for stem cell research center
Duke University has received a $10.2 million grant from the Robertson Foundation to create a Translational Cell Therapy Center. The center will focus on the University’s cell therapy research and treatment programs. The center will look at treatments for cancer, cerebral palsy, stroke, and brain injuries.